Category: MS Drug Therapies

Infusion Treatments: Benefits and Side Effects

Multiple sclerosis (MS) is an autoimmune disease that affects the central nervous system (CNS). With MS, your immune system mistakenly…

Stuart Schlossman

Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-to-head Phase III multiple sclerosis studies

Aug 30, 2019 In ASCLEPIOS I and II, ofatumumab (OMB157) met primary endpoints to reduce the annualized relapse rate over…

Stuart Schlossman

Managing MS Symptoms and the Medications

A wide variety of medications are used to help manage the symptoms of MS.  CLICK HERE to see  common symptoms of MS…

Stuart Schlossman

MS Therapies Among Limited Offerings Through AllianceRx Walgreens Prime

August 16, 2019 Medications for treating certain rare and chronic conditions,  including multiple sclerosis (MS), are now available from the…

Stuart Schlossman

Ofatumumab (Arzerra) in clinical studies for Multiple Sclerosis (MS)

Ofatumumab is an antibody against a protein called CD20, which is found on the surface of certain types of immune cells…

Stuart Schlossman

Rebif Cost-effective and Can Reduce Brain Lesions in RRMS Patients, Data Show

Merck KGaA presented new evidence supporting the safety and clinical efficacy of Rebif (interferon beta-1a) for relapsing-remitting multiple sclerosis (RRMS) at the 5th Congress of the European…

Stuart Schlossman

Disease Modifying Therapies in the over 60s

Sophie McConnell 28 May 2019 Dr Jonathan White explains the results of two separate studies which looked at treatment of…

Stuart Schlossman

Video: MS Medications – Which Multiple Sclerosis Drugs Need a Washout?

In this video @AaronBosterMD teach you about washout periods for each of the MS medications. :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: To receive ‘The MS BEACON’ e-Newsletter, Click…

Stuart Schlossman

New Phase 3 Interim Results Support Safety and Efficacy of Diroximel Fumarate in Multiple Sclerosis

Interim EVOLVE-MS-1 Data Support Efficacy, Tolerability of Diroximel Fumarate in Relapsing Multiple Sclerosis Diroximel fumarate may be an effective treatment…

Stuart Schlossman

Accessing your medicines (MS and non-MS) can be confusing. BUT It doesn’t have to be.

PhRMA member companies are committed to helping patients make more informed health care decisions by providing more transparency about medicine…

Stuart Schlossman

Categories

Latest Blog Posts